Alzheimer's Association Rally for Access

We’ve made progress in the fight against Alzheimer’s with new FDA-approved treatments, but an unprecedented and unjust decision by the Centers for Medicare & Medicaid Services (CMS) is blocking access to these treatments! 

CMS is denying access to all current and future FDA-approved treatments addressing the underlying cause of the disease. This coverage determination was the first time ever that CMS chose to not have Medicare cover an FDA-approved drug. Which is why CMS must reverse its decision!

These treatments are proven to slow the progression of the disease. Leading Alzheimer’s researchers and clinicians overwhelmingly agree that patients should have access to these treatments.

Access to these treatments means more time for the person living with early Alzheimer’s. They allow people more time with loved ones, more time to enjoy life, and remain independent longer.

Which is why The Alzheimer's Association is rallying for #AccessNow on June 20th at Jefferson Square Park in Downtown Louisville. Please register to attend and receive more details!

Raise your voice with advocates from across the state and region as we demand CMS provide #AccessNow!

To Register, Click HERE